10-K Filing

GRINDR INC. CIK: 1820144 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001140361-21-010832`
Period End Date	20201231
Filing Date	20210330
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	tinv-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 23 Income Statement 4 Cash Flow Statement 26 Stockholders Equity 9

Balance Sheet 23 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$1.14M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$262.50K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.41M	USD	Point-in-time
Preference shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and marketable securities held in Trust Account	`AssetsHeldInTrustNoncurrent`	$278.77M	USD	Point-in-time
Cash and marketable securities held in Trust Account	`AssetsHeldInTrustNoncurrent`	$278.76M	USD	Point-in-time
Preference shares, shares authorized (in shares)	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$280.18M	USD	Point-in-time
Preference shares, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preference shares, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$37.07K	USD	Point-in-time
Accrued offering costs	`AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent`	$26.78K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$63.85K	USD	Point-in-time
Deferred underwriting fee payable	`DeferredUnderwritingFeePayableNonCurrent`	$9.66M	USD	Point-in-time
Total Liabilities	`Liabilities`	$9.72M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Class A ordinary shares subject to possible redemption, 26,281,596 shares at $10.10 per share	`TemporaryEquityCarryingAmountAttributableToParent`	$265.46M	USD	Point-in-time
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-110.28K	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	-	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$5.00M	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$280.18M	USD	Point-in-time

Income Statement 4 line items

Line Item	Tag	Value	Unit	Period
Formation and operating costs	`OperatingExpenses`	$124.92K	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-124.92K	USD	2 Qtrs
Interest earned on marketable securities held in Trust Account	`InvestmentIncomeInterest`	$14.65K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-110.28K	USD	2 Qtrs

Cash Flow Statement 26 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-110.28K	USD	2 Qtrs
Payment of formation costs through issuance of Class B ordinary shares	`PaymentOfFormationCostsThroughIssuanceOfOrdinaryShares`	$5.00K	USD	2 Qtrs
Interest earned on marketable securities held in Trust Account	`InvestmentIncomeInterest`	$14.65K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$262.50K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$37.07K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-345.36K	USD	2 Qtrs
Investment of cash in Trust Account	`PaymentsForProceedsFromInvestments`	$278.76M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-278.76M	USD	2 Qtrs
Proceeds from sale of Units, net of underwriting discounts paid	`ProceedsFromIssuanceInitialPublicOffering`	$270.48M	USD	2 Qtrs
Proceeds from sale of private placement warrants	`ProceedsFromIssuanceOfWarrants`	$10.28M	USD	2 Qtrs
Advances from related party advanced prior to IPO	`ProceedsFromLinesOfCredit`	$700.00K	USD	2 Qtrs
Repayment of advances from related party advanced prior to IPO	`RepaymentsOfLinesOfCredit`	$700.00K	USD	2 Qtrs
Proceeds from promissory note - related party	`ProceedsFromRelatedPartyDebt`	$300.00K	USD	2 Qtrs
Repayment of promissory note - related party	`RepaymentsOfRelatedPartyDebt`	$300.00K	USD	2 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$509.87K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$280.25M	USD	2 Qtrs
Net Change in Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.14M	USD	2 Qtrs
Cash - Beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.14M	USD	Point-in-time
Cash - Beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash - Ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.14M	USD	Point-in-time
Cash - Ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Initial classification of ordinary shares subject to possible redemption	`InitialClassificationOfCommonStockSubjectToRedemption`	$265.56M	USD	2 Qtrs
Change in value of ordinary shares subject to possible redemption	`IncreaseDecreaseInValueOfCommonStockSubjectToRedemption`	$-104.71K	USD	2 Qtrs
Deferred underwriting fee payable	`DeferredUnderwritingFeeChargedToAdditionalPaidInCapital`	$9.66M	USD	2 Qtrs
Offering costs included in accrued offering costs	`OfferingCostsIncludedInAccruedOfferingCosts`	$26.78K	USD	2 Qtrs
Offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares	`OfferingCostsPaidFromProceedsFromIssuanceOfShares`	$20.00K	USD	2 Qtrs

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	-	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$5.00M	USD	Point-in-time
Issuance of Class B ordinary shares to Sponsor	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	2 Qtrs
Sale of 27,600,000 Units, net of underwriting discounts and offering costs	`SharesIssuedInInitialPublicOfferingDuringPeriodValueNewIssues`	$260.26M	USD	2 Qtrs
Sale of 10,280,000 Private Placement Warrants	`ClassOfWarrantOrRightIssuedInPrivatePlacementValue`	$10.28M	USD	2 Qtrs
Ordinary shares subject to possible redemption	`StockRedeemedOrCalledDuringPeriodValue`	$265.46M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-110.28K	USD	2 Qtrs
Ending balance	`StockholdersEquity`	-	USD	Point-in-time
Ending balance	`StockholdersEquity`	$5.00M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.